Matrix metalloproteinases are associated with increased blood-brain barrier opening in vascular cognitive impairment

Stroke

Volumn 42, Issue 5, 2011, Pages 1345-1350

  Candelario Jalil, Eduardo ^a   Thompson, Jeffrey ^a   Taheri, Saeid ^a   Grossetete, Mark ^a   Adair, John C ^a   Edmonds, Elaine ^a   Prestopnik, Jillian ^a   Wills, John ^a   Rosenberg, Gary A ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

Binswanger disease; blood brain barrier; brain; matrix proteins; pathobiology; vascular cognitive impairment; vascular dementia; white matter disease

Indexed keywords

ALBUMIN; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; MYELIN BASIC PROTEIN; SERUM ALBUMIN; STROMELYSIN;

ADULT; ALZHEIMER DISEASE; ARTICLE; BINSWANGER ENCEPHALOPATHY; BLOOD BRAIN BARRIER; CEREBROSPINAL FLUID ANALYSIS; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; FLUORESCENCE; HUMAN; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; WHITE MATTER; ZYMOGRAPHY;

ALBUMINS; ALZHEIMER DISEASE; BLOOD-BRAIN BARRIER; CASE-CONTROL STUDIES; COGNITION DISORDERS; FEMALE; HUMANS; LEUKOARAIOSIS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 3; MATRIX METALLOPROTEINASE 9; STROKE; VASCULAR DISEASES;

EID: 79955470208     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.600825     Document Type: Article

References (26)

1. Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, Powers WJ, DeCarli C, Merino JG, Kalaria RN, Vinters HV, Holtzman DM, Rosenberg GA, Wallin A, Dichgans M, Marler JR, Leblanc GG. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmo-nization standards. Stroke. 2006;37:2220-2241. (Pubitemid 44337162)
2. Caplan LR. Binswanger's disease\revisited. Neurology. 1995;45: 626-633.
3. Olszewski J. Subcortical arteriosclerotic encephalopathy. Review ofthe literature on the so-called Binswanger's disease and presentation of two cases. World Neurol. 1962;3:359-375.
4. Bowler JV. Modern concept of vascular cognitive impairment Br Med Bull. 2007;83:291-305. (Pubitemid 47614262)
5. Roman GC, Erkinjuntti T, Wallin A, Pantoni L, Chui HC. Subcortical ischaemic vascular dementia. Lancet Neurol. 2002;1:426-436. (Pubitemid 37159153)
6. Hanyu H, Asano T, Tanaka Y, Iwamoto T, Takasaki M, Abe K. Increased blood-brain barrier permeability in white matter lesions ofBinswanger's disease evaluated by contrast-enhanced MRI. Dement Geriatr Cogn Disord. 2002;14:1-6. (Pubitemid 34621574)
7. Wardlaw JM, Doubal F, Armitage P, Chappell F, Carpenter T, Munoz Maniega S, Farrall A, Sudlow C, Dennis M, Dhillon B. Lacunar stroke is associated with diffuse blood-brain barrier dysfunction. Ann Neurol. 2009;65:194-202.
8. Rosenberg GA. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol. 2009;8:205-216.
9. Candelario-Jalil E, Yang Y, Rosenberg GA. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuro-inflammation and cerebral ischemia. Neuroscience. 2009;158:983-994.
10. Yang Y, Estrada EY, Thompson JF, Liu W, Rosenberg GA. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat J Cereb Blood Flow Metab. 2007;27:697-709. (Pubitemid 46474608)
11. Chandler S, Coates R, Gearing A, Lury J, Wells G, Bone E. Matrix metalloproteinases degrade myelin basic protein. Neurosci Lett. 1995; 201:223-226. (Pubitemid 26009985)
12. Maeda A, Sobel RA. Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions. J Neuropathol Exp Neurol. 1996;55:300-309. (Pubitemid 26085579)
13. Clark AW, Krekoski CA, Bou SS, Chapman KR, Edwards DR. Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia. Neurosci Lett. 1997;238:53-56. (Pubitemid 28015782)
14. Anthony DC, Ferguson B, Matyzak MK, Miller KM, Esiri MM, Perry VH. Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke. Neuropathol Appl Neurobiol. 1997;23:406-415. (Pubitemid 27440481)
15. Rosenberg GA, Sullivan N, Esiri MM. White matter damage is associated with matrix metalloproteinases in vascular dementia. Stroke. 2001;32: 1162-1168.
16. Adair JC, Charlie J, Dencoff JE, Kaye JA, Quinn JF, Camicioli RM, Stetler-Stevenson WG, Rosenberg GA. Measurement of gelatinase B (MMP-9) in the cerebrospinal fluid of patients with vascular dementia and Alzheimer disease. Stroke. 2004;35:e159-e162.
17. Liuzzi GM, Trojano M, Fanelli M, Avolio C, Fasano A, Livrea P, Riccio P. Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis. Mult Scler. 2002;8:222-228. (Pubitemid 34654058)
18. Mandler RN, Dencoff JD, Midani F, Ford CC, Ahmed W, Rosenberg GA. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in cerebrospinal fluid differ in multiple sclerosis and Devic's neuromyelitis optica. Brain. 2001;124:493-498. (Pubitemid 32221316)
19. Nagase H, Fields CG, Fields GB. Design and characterization of a fluorogenic substrate selectively hydrolyzed by stromelysin 1 (matrix metalloproteinase-3). J Biol Chem. 1994;269:20952-20957. (Pubitemid 24266460)
20. Bennett DA, Wilson RS, Gilley DW, Fox JH. Clinical diagnosis of Binswanger's disease. JNeurol Neurosurg Psychiatry. 1990;53:961-965. (Pubitemid 20378898)
21. Fisher CM. Binswanger's encephalopathy: areview. JNeurol. 1989;236: 65-79.
22. Zhang WW, Olsson Y. The angiopathy of subcortical arteriosclerotic encephalopathy (Binswanger's disease): immunohistochemical studies using markers for components of extracellular matrix, smooth muscle actin and endothelial cells. Acta Neuropathol. 1997;93:219-224. (Pubitemid 27104416)
23. Feigin I, Popoff N. Neuropathological changes late in cerebral edema: the relationship to trauma, hypertensive disease and Binswanger's encepha-lopathy. J Neuropathol Exp Neurol. 1963;22:500-511.
24. Akiguchi I, Tomimoto H, Suenaga T, Wakita H, Budka H. Blood-brain barrier dysfunction in Binswanger's disease; an immunohistochemical study. Acta Neuropathol. 1998;95:78-84. (Pubitemid 28075930)
25. Wardlaw JM, Sandercock PA, Dennis MS, Starr J. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke. 2003;34:806-812.
26. Schmidt R, Scheltens P, Erkinjuntti T, Pantoni L, Markus HS, Wallin A, Barkhof F, Fazekas F. White matter lesion progression: a surrogate endpoint for trials in cerebral small-vessel disease. Neurology. 2004;63:139-144 (Pubitemid 38943791)